Featured Research

from universities, journals, and other organizations

Scientists Uncover Possible Cause Of Colitis

Date:
October 6, 1999
Source:
University Of California, San Francisco
Summary:
In experiments with laboratory mice, a team of American, Canadian and Italian researchers have discovered a cause and potential treatment for painful colitis and other forms of inflammatory bowel disease.

In experiments with laboratory mice, a team of American, Canadian and Italianresearchers have discovered a cause and potential treatment for painful colitisand other forms of inflammatory bowel disease.

The often painful conditions can arise from the action of one of the body'ssignaling chemicals, a peptide called substance P, released by sensory nervesin the intestines and known to be involved in other inflammations.

The scientists had earlier determined that bowel inflammation restrictsproduction of an enzyme that would otherwise break down substance P. In thecurrent study, they found that colitis was up to five times worse if micelacked the enzyme, known as NEP. When they reintroduced NEP into these mice,the bowel inflammation subsided, they report.

Their study shows that loss of the NEP enzyme fuels inflammation becausesubstance P doesn't break down and so continues to cause colitis. The findingalso shows that breaking this cycle - either by administering the NEP enzyme orblocking substance P with a drug - can dramatically reduce the inflammation.

Substance P-blocking drugs are already under development to treat depression,asthma and other conditions. If studies show that NEP and substance P play asimilar role in humans as they do in the mice, then drugs already in thepipeline could prove effective against colitis, said Nigel Bunnett, PhD,professor of surgery and physiology at the University of California, SanFrancisco and designer of the study

The research results are published in the current issue (Sept. 26) of theProceedings of the National Academy of Sciences (PNAS).

Inflammations of the pancreas and skin also appear to be aggravated andcontrolled by the NEP/substance P cycle, Bunnett said, and these too may betreatable with substance P blockers.

Current first-line treatments for inflammatory bowel disease often have limited effect or carry serious side effects such as osteoporosis and mood shifts, said co-investigator Steven Collins, MD, professor of medicine and head of the division of gastroenterology at McMaster University in Ontario, Canada. Surgery can effectively treat some, but not all, cases.

For unknown reasons, some patients don't respond to conventionalanti-inflammatory therapies, and these patients may be particularly prone tothe nerve-related mechanisms of inflammation that was this study's focus,Collins said.

The researchers examined the mechanisms that control colitis by studying"knockout" mice that lacked the gene for NEP, and therefore could not normallydegrade substance P. They found that NEP knockout mice had twice as muchsubstance P in the intestinal wall than normal mice. The NEP-deficient micealso showed a four-fold greater "leakage" of proteins and immune cells fromthe blood into the wall of the colon, which may predispose the animals todevelop inflammation, the scientists reported.

The researchers were able to counter both the more severe colitis and thisabnormal leakage by giving the mice either a genetically engineered form of NEPor a drug to interfere with the action of substance P activity (a "substance Preceptor antagonist").

Colitis causes often severe abdominal pain and bloody diarrhea, Collins said.As many as one person in 2,000 suffers from some form of inflammatory boweldisease at any time and the treatments are sometimes inadequate or too burdenedby side effects.

Sergio Sturiale, MD, research fellow at the University of Messina, Italy, isfirst author of the PNAS paper, based on research he did at McMasterUniversity with Collins and colleagues.

Co-authors on the paper, along with Suriale, Collins and Bunnett, are GiovanniBarbara, MD, assistant professor at the University of Bologna; Bosheng Qiu,MD, a postdoctoral fellow at McMaster.

Other researchers include Michela Figini, PhD, postdoctoral fellow, andPierangelo Geppetti, MD, professor, both at the University of Ferrara; NormaGerard, PhD, and Craig Gerard, MD, at Harvard Medical School; and EileenGrady, PhD, assistant professor of surgery at UC San Francisco.

The research was funded by the National Institutes of Health, the Crohn's andColitis Foundation of America, and NATO.


Story Source:

The above story is based on materials provided by University Of California, San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, San Francisco. "Scientists Uncover Possible Cause Of Colitis." ScienceDaily. ScienceDaily, 6 October 1999. <www.sciencedaily.com/releases/1999/10/991006075750.htm>.
University Of California, San Francisco. (1999, October 6). Scientists Uncover Possible Cause Of Colitis. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/1999/10/991006075750.htm
University Of California, San Francisco. "Scientists Uncover Possible Cause Of Colitis." ScienceDaily. www.sciencedaily.com/releases/1999/10/991006075750.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Ebola Doctor Says Border Controls Critical

Ebola Doctor Says Border Controls Critical

AP (Sep. 22, 2014) A Florida doctor who helped fight the expanding Ebola outbreak in West Africa says the disease can be stopped, but only if nations quickly step up their response and make border control a priority. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins